Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin

NCT01466504 · clinicaltrials.gov ↗
TERMINATED
Status
4
Enrollment
OTHER
Sponsor class

Stopped Accrual did not meet expectations. Over nearly 2 years just 4 subjects were treated on study. The goal of 30 subjects was not attainable.

Conditions

Interventions

Sponsor

Dartmouth-Hitchcock Medical Center